المؤلفون: Andre, T., Vernerey, D., Im, S. A., Bodoky, G., Buzzoni, R., Reingold, S., Rivera, F., McKendrick, J., Scheithauer, W., Ravit, G., Fountzilas, G., Yong, W. P., Isaacs, R., Österlund, P., Liang, J. T., Creemers, G. J., Rakez, M., Van Cutsem, E., Cunningham, D., Tabernero, J., de Gramont, A.

المساهمون: HUS Comprehensive Cancer Center, Department of Oncology, Clinicum

مصطلحات موضوعية: adjuvant, bevacizumab, colon cancer, FOLFOX, XELOX, OPEN-LABEL, STAGE-II, OXALIPLATIN, FLUOROURACIL, LEUCOVORIN, IRINOTECAN, TRIAL, CHEMOTHERAPY, CAPECITABINE, CARCINOMA, 3122 Cancers

وصف الملف: application/pdf

العلاقة: This updated analysis was supported by F. Hoffmann-La Roche AG (no grant number applicable). Study sponsors (Roche for AVANT and GERCOR for S-AVANT) were involved in the study design, data interpretation, and the decision to submit the report for publication in conjunction with the authors. Employees of GERCOR collected and managed the data and undertook data analysis. The principal investigator (AdG) had full access to all study data and had the final responsibility for the decision to submit for publication.; Andre , T , Vernerey , D , Im , S A , Bodoky , G , Buzzoni , R , Reingold , S , Rivera , F , McKendrick , J , Scheithauer , W , Ravit , G , Fountzilas , G , Yong , W P , Isaacs , R , Österlund , P , Liang , J T , Creemers , G J , Rakez , M , Van Cutsem , E , Cunningham , D , Tabernero , J & de Gramont , A 2020 , ' Bevacizumab as adjuvant treatment of colon cancer : updated results from the S-AVANT phase III study by the GERCOR Group ' , Annals of Oncology , vol. 31 , no. 2 , pp. 246-256 . https://doi.org/10.1016/j.annonc.2019.12.006Test; 57eabb66-17e2-4433-b227-6f95385f49ec; http://hdl.handle.net/10138/326398Test; 000516712400012

الإتاحة: http://hdl.handle.net/10138/326398Test

المؤلفون: André, T, Vernerey, D, Im, SA, Bodoky, G, Buzzoni, R, Reingold, S, Rivera, F, McKendrick, J, Scheithauer, W, Ravit, G, Fountzilas, G, Yong, WP, Isaacs, R, Österlund, P, Liang, JT, Creemers, GJ, Rakez, M, Van Cutsem, E, Cunningham, D, Tabernero, J, de Gramont, A

المساهمون: Cunningham, David

مصطلحات موضوعية: Humans, Colonic Neoplasms, Organoplatinum Compounds, Fluorouracil, Leucovorin, Antineoplastic Combined Chemotherapy Protocols, Neoplasm Staging, Disease-Free Survival, Chemotherapy, Adjuvant, Bevacizumab

وصف الملف: Print-Electronic; 256; application/pdf

العلاقة: Annals of oncology : official journal of the European Society for Medical Oncology, 2020, 31 (2), pp. 246 - 256; https://repository.icr.ac.uk/handle/internal/4374Test

الإتاحة: https://doi.org/10.1016/j.annonc.2019.12.006Test
https://repository.icr.ac.uk/handle/internal/4374Test

المؤلفون: André, T., Vernerey, D., Im, S.A., Bodoky, G., Buzzoni, R., Reingold, S., Rivera, F., Mckendrick, J., Scheithauer, W., Ravit, G., Fountzilas, G., Yong, W.P., Isaacs, R., Österlund, P., Liang, J.T., Creemers, G.J., Rakez, M., van Cutsem, E., Cunningham, D., Tabernero, J., de Gramont, A.

المساهمون: CHU Saint-Antoine AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Interactions hôte-greffon-tumeur, ingénierie cellulaire et génique - UFC (UMR INSERM 1098) (RIGHT), Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang Bourgogne-Franche-Comté (EFS BFC)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté COMUE (UBFC)-Université Bourgogne Franche-Comté COMUE (UBFC), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Seoul National University Hospital, IRCCS Istituto Nazionale dei Tumori Milano, Hospital Universitario Marqués de Valdecilla Santander, Box Hill Hospital, Medizinische Universität Wien = Medical University of Vienna, Tel Aviv University (TAU), Aristotle University of Thessaloniki, National University of Singapore (NUS), Helsingin yliopisto = Helsingfors universitet = University of Helsinki, National Taiwan University Hospital Taipei, Catharina Hospital Eindhoven, Fondation Aide et Recherche en Cancérologie Digestive (Levallois-Perret) (ARCAD), Catholic University of Leuven = Katholieke Universiteit Leuven (KU Leuven), Royal Marsden NHS Foundation Trust, Vall d'Hebron University Hospital Barcelona

المصدر: ISSN: 0923-7534.

مصطلحات موضوعية: FOLFOX, XELOX, adjuvant, bevacizumab, colon cancer, [SDV]Life Sciences [q-bio]

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31959341; hal-03489860; https://hal.science/hal-03489860Test; https://hal.science/hal-03489860/documentTest; https://hal.science/hal-03489860/file/S092375341953229X.pdfTest; PII: S0923-7534(19)53229-X; PUBMED: 31959341

الإتاحة: https://doi.org/10.1016/j.annonc.2019.12.006Test
https://hal.science/hal-03489860Test
https://hal.science/hal-03489860/documentTest
https://hal.science/hal-03489860/file/S092375341953229X.pdfTest

المؤلفون: Chibaudel, Benoist, Henriques, Julie, Rakez, Manel, Brenner, Baruch, Kim, Tae Won, Martínez-Villacampa, Mercedes, Tabernero Caturla, Josep

المساهمون: Institut Català de la Salut, Chibaudel B Department of Medical Oncology, Franco-British Hospital–Fondation Cognacq-Jay, Levallois-Perret, France. Statistical Unit, Aide et Recherche en Cancérologie Digestive, Foundation, Levallois-Perret, France. Henriques J Methodology and Quality of Life Unit in Oncology, University Hospital of Besançon, Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche 1098, Besançon, France. Rakez M Statistical Unit, Aide et Recherche en Cancérologie Digestive, Foundation, Levallois-Perret, France. Brenner B Institute of Oncology, Davidoff Cancer Center, Rabin Medical Center, Petah Tiqva, Tel Aviv University, Tel Aviv, Israel. Kim TW Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Martinez-Villacampa M Department of Medical Oncology, Institut Català d'Oncologia-Bellvitge Institute for Biomedical Research, L’Hospitalet, Barcelona, Spain. Tabernero J Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat de Vic–Universitat Central de Catalunya, International Oncology Bureau–Quiron, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Còlon - Càncer, Quimioteràpia combinada, Avaluació de resultats (Assistència sanitària), DISEASES::Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms::Intestinal Neoplasms::Colorectal Neoplasms::Colonic Neoplasms, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Clinical Protocols::Antineoplastic Protocols::Antineoplastic Combined Chemotherapy Protocols, Other subheadings::Other subheadings::/therapeutic use, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome::Disease-Free Survival, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias gastrointestinales::neoplasias intestinales::neoplasias colorrectales::neoplasias del colon, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::protocolos clínicos::protocolos antineoplásicos::protocolos de quimioterapia antineoplásica combinada, Otros calificadores::Otros calificadores::/uso terapéutico, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento::supervivencia sin enfermedad

وصف الملف: application/pdf

العلاقة: Jama Network Open;3(10); https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2771857Test; Chibaudel B, Henriques J, Rakez M, Brenner B, Kim TW, Martinez-Villacampa M, et al. Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer. JAMA Netw Open. 2020 Oct 19;3(10):e2020425.; https://hdl.handle.net/11351/6342Test; 000586427500004

الإتاحة: https://doi.org/10.1001/jamanetworkopen.2020.20425Test
https://hdl.handle.net/11351/6342Test

المؤلفون: Andrés Cervantes, Veronique Guerin-Meyer, Josep Tabernero, Hans-Joachim Schmoll, Julie Henriques, Haiko J. Bloemendal, Paulo M. Hoff, Laurent Mineur, Arnaud Roth, Derek J. Jonker, Eric Van Cutsem, Alice Dewdney, Mercedes Martinez-Villacampa, Enrique Aranda, Benoist Chibaudel, Chiara Banzi, Thitiya Dejthevaporn, Tae Won Kim, Manel Rakez, Markus Moehler, Katharine Shim, Javier Gallego-Plazas, Aimery de Gramont, Baruch Brenner, Thierry André

المساهمون: Institut Català de la Salut, [Chibaudel B] Department of Medical Oncology, Franco-British Hospital–Fondation Cognacq-Jay, Levallois-Perret, France. Statistical Unit, Aide et Recherche en Cancérologie Digestive, Foundation, Levallois-Perret, France. [Henriques J] Methodology and Quality of Life Unit in Oncology, University Hospital of Besançon, Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche 1098, Besançon, France. [Rakez M] Statistical Unit, Aide et Recherche en Cancérologie Digestive, Foundation, Levallois-Perret, France. [Brenner B] Institute of Oncology, Davidoff Cancer Center, Rabin Medical Center, Petah Tiqva, Tel Aviv University, Tel Aviv, Israel. [Kim TW] Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. [Martinez-Villacampa M] Department of Medical Oncology, Institut Català d'Oncologia-Bellvitge Institute for Biomedical Research, L’Hospitalet, Barcelona, Spain. [Tabernero J] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat de Vic–Universitat Central de Catalunya, International Oncology Bureau–Quiron, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia
Dipòsit Digital de la UB
Universidad de Barcelona
JAMA Network Open, 3
Jama Network Open
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
JAMA Network Open, 3, 10

مصطلحات موضوعية: medicine.medical_specialty, Bevacizumab, Perforation (oil well), Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms::Intestinal Neoplasms::Colorectal Neoplasms::Colonic Neoplasms [DISEASES], Gastroenterology, Quimioteràpia combinada, law.invention, Capecitabine, neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias gastrointestinales::neoplasias intestinales::neoplasias colorrectales::neoplasias del colon [ENFERMEDADES], All institutes and research themes of the Radboud University Medical Center, Randomized controlled trial, Càncer colorectal, Interquartile range, law, Còlon - Càncer, Internal medicine, medicine, Other subheadings::/therapeutic use [Other subheadings], terapéutica::protocolos clínicos::protocolos antineoplásicos::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Diagnosis::Prognosis::Treatment Outcome::Disease-Free Survival [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Otros calificadores::/uso terapéutico [Otros calificadores], business.industry, Hazard ratio, General Medicine, Therapeutics::Clinical Protocols::Antineoplastic Protocols::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], diagnóstico::pronóstico::resultado del tratamiento::supervivencia sin enfermedad [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Colorectal cancer, Chemotherapy regimen, Oxaliplatin, Urological cancers Radboud Institute for Health Sciences [Radboudumc 15], Avaluació de resultats (Assistència sanitària), Monoclonal antibodies, business, Anticossos monoclonals, medicine.drug

وصف الملف: application/pdf; Electronic

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46de75845792226df9bdd7d267133c2fTest
https://doi.org/10.1001/jamanetworkopen.2020.20425Test